Vaccine News and Research

Latest Vaccine News and Research

COVID-19 vaccine candidate approved for human clinical testing

A few days from now the first human will be vaccinated with a Danish vaccine candidate against COVID-19.

9 Mar 2021

Two doses of Pfizer-BioNTech SARS-CoV-2 vaccine induce humoral protection against U.K. and S.A. variants

Researchers at the Pitié Salpêtrière Hospital, Department of Virology, Paris, France determined that in BNT162b2-vaccinated participants who received two doses, their sera harbored at least a neutralizing titer against the three SARS-CoV-2 variants.

8 Mar 2021

Current vaccines and therapies may be less effective at neutralizing new SARS-CoV-2 variants

A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.

8 Mar 2021

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

The currently developed vaccines against SARS-CoV-2 include the RBD in their immunogen. With a similar objective, a new study developed an RBD protein-based vaccine candidate against the SARS-CoV-2, using self-assembling Helicobacter pylori-bullfrog ferritin nanoparticles as an antigen delivery system. The study is published recently in the journal mBio (by the American Society of Microbiology).

8 Mar 2021

SARS-CoV-2 vaccines modeled on South African variant may offer broad protection against other variants

Researchers in South Africa have submitted evidence that suggests that vaccines modeled on the South African variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) would not only be effective on that strain but would also function well against other variants.

8 Mar 2021

Continued vigilance needed as COVID lockdown is relaxed in England, warn researchers

Researchers have reported findings from round nine of the REal-time Assessment of Community Transmission Study (REACT-1) that estimates community prevalence of infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in England.

8 Mar 2021

Study: More than 2/3 of Indiana nursing home staff show willingness to receive COVID-19 vaccine

In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.

8 Mar 2021

New academic spin-out based in Finland introduces a nasal spray vaccine against COVID

Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID.

8 Mar 2021

Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response

A team of scientists from Israel has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2, in inducing host humoral immune response. The findings reveal that the vaccine is capable of inducing strong anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and that the response varies significantly with age. The study is currently available on the medRxiv* preprint server.

8 Mar 2021

Radiotherapy-resistant cancers could be rendered susceptible through immunotherapy treatment

Cancers that are resistant to radiotherapy could be rendered susceptible through treatment with immunotherapy, a new study suggests.

8 Mar 2021

Impairments in immune response contribute to severe COVID-19

New research by a team of scientists at University Hospital RWTH Aachen in Germany and Erasmus Medical Centre in The Netherlands characterized changes in CD8+ T cells in response to SARS-CoV-2.

8 Mar 2021

Biden’s criticism of Trump team’s vaccine contracts is a stretch

During a March 2 news conference on the covid-19 pandemic, President Joe Biden claimed that former President Donald Trump's administration did not ensure there would be enough vaccines for the American public.

8 Mar 2021

On vacci-dating: Singles seem enamored of sharing vaccination status online. Is that wise?

As cold weather descended upon Washington, D.C., last fall, I deleted my dating apps.

8 Mar 2021

Diphtheria is evolving to become antibiotic-resistant and could lead to vaccine escape

Diphtheria - a relatively easily-preventable infection - is evolving to become resistant to a number of classes of antibiotics and in future could lead to vaccine escape, warn an international team of researchers from the UK and India.

8 Mar 2021

Monoclonal antibodies can be an effective tool in the global fight against malaria

Scientists at Walter Reed Army Institute of Research, in collaboration the Duke University, have confirmed that monoclonal antibodies can be an effective tool in the global fight against malaria.

8 Mar 2021

California’s vaccine appointment website has glitches. No surprise?

California rolled out a statewide covid vaccination website this week aiming to streamline the appointment process after months of criticism, but the site is riddled with its own snags, preventing many from signing up for shots.

5 Mar 2021

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

A monoclonal antibody "cocktail" developed at Vanderbilt University Medical Center (VUMC) to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published in the journal Nature Medicine.

5 Mar 2021

Vaccine News and Research

Latest Vaccine News and Research

COVID-19 vaccine candidate approved for human clinical testing

Two doses of Pfizer-BioNTech SARS-CoV-2 vaccine induce humoral protection against U.K. and S.A. variants

Current vaccines and therapies may be less effective at neutralizing new SARS-CoV-2 variants

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

SARS-CoV-2 vaccines modeled on South African variant may offer broad protection against other variants

Continued vigilance needed as COVID lockdown is relaxed in England, warn researchers

Study: More than 2/3 of Indiana nursing home staff show willingness to receive COVID-19 vaccine

New academic spin-out based in Finland introduces a nasal spray vaccine against COVID

Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response

Radiotherapy-resistant cancers could be rendered susceptible through immunotherapy treatment

Impairments in immune response contribute to severe COVID-19

Biden’s criticism of Trump team’s vaccine contracts is a stretch

On vacci-dating: Singles seem enamored of sharing vaccination status online. Is that wise?

Diphtheria is evolving to become antibiotic-resistant and could lead to vaccine escape

Monoclonal antibodies can be an effective tool in the global fight against malaria

California’s vaccine appointment website has glitches. No surprise?

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

Firefighters — ‘health care providers on a truck’ — signal pandemic burnout

One dose of SARS-CoV-2 vaccine candidate boosts neutralizing antibody response in COVID-19 convalescents

A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in